Evaluates sarcosine detection in prostate cancer cells, suggesting a new screening method.
to Ag nanoparticles, thereby restoring the fluorescence of N-CQDs. The sensor demonstrated a linear response to sarcosine in the range of 10-60 µM with a detection limit of 2.1 µM, and exhibited high selectivity against common interfering substances. Furthermore, the platform was successfully applied to detect sarcosine in lysates of prostate cell lines, revealing significantly elevated sarcosine levels in androgen-independent PC-3 cells compared to benign (BPH-1) and androgen-sensitive (LNCaP) cells. This work presents a cost-effective, and cell-compatible fluorescence strategy for sarcosine detection, holding potential for PCa early screening and metabolic profiling.
No takes yet. Share an insight, caveat, or question.
Shen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: